rInsulin2-SaCas9 AAV (Serotype 9)

AAV (adeno-associated virus) vectors have become an important tool for gene therapy and genetic research due to their ability to infect a wide range of dividing and non-dividing cell types with minimal immune response. rInsulin2-SaCas9 AAV (serotype 9) is a unique vector that incorporates the Staphylococcus aureus Cas9 (SaCas9) gene editing protein driven by the rInsulin2 promoter. The advantage of choosing SaCas9 is that it is smaller than the more common SpyCas9 derived from Streptococcus pyogenes and can be more easily packaged within the AAV vector. This property makes SaCas9 an ideal tool for in vivo applications where vector capacity is limited. The rInsulin2 promoter refers to a specific DNA region that regulates the expression of the rat insulin 2 gene. Promoters are DNA sequences located upstream of the start site of a gene and play a key role in controlling when and where a gene is activated. In the case of the rInsulin2 promoter, it is responsible for initiating transcription of the insulin 2 gene, primarily in pancreatic beta cells, where insulin is produced. The promoter contains a specific sequence that enables it to be recognized and bound by transcription factors, thereby initiating and regulating the transcription of the insulin 2 gene. The rInsulin2 promoter is used to specifically direct the expression of SaCas9.